GlaxoSmithKline Pharmaceuticals Limited in SBI Midcap Fund

Held in 41 of the fund’s 41 disclosed months. Still held as of Sep 2026.

Current weight

1.40%

₹327 Cr in Sep 2026

Weight over time

Share of the fund's portfolio each month. A gap is a month the fund disclosed without this stock.

Weight of GlaxoSmithKline Pharmaceuticals Limited in SBI Midcap Fund, Jan 2023 to Sep 2026.

New entered Jan 2023 (held from the first disclosure)still held41 months · peak 2.50%

Weight, value and quantity by month
Month	Weight	Value	Shares	Δ shares
Sep 2026	1.40%	₹327 Cr	11,80,000
Aug 2026	1.47%	₹360 Cr	11,80,000	−20,000
Jul 2026	1.31%	₹319 Cr	12,00,000
Jun 2026	1.22%	₹294 Cr	12,00,000
May 2026	1.13%	₹265 Cr	12,00,000
Apr 2026	1.21%	₹280 Cr	12,00,000
Mar 2026	1.33%	₹274 Cr	12,00,000
Feb 2026	1.33%	₹309 Cr	12,00,000
Jan 2026	1.29%	₹288 Cr	12,00,000
Dec 2025	1.27%